aluates Reports

$ 0.0

Automative

Global Pneumococcal Vaccine Polyvalent Market Research Report 2025

Published Date: August 2025

Report Code: QYRE-Auto-37P6892

Global Pneumococcal Vaccine Polyvalent Market Insights Forecast to 2028

BUY CHAPTERS

Global Pneumococcal Vaccine Polyvalent Market Research Report 2025

Code: QYRE-Auto-37P6892

Report

August 2025

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck

Pfizer Inc

Pneumococcal Vaccine Polyvalent Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pneumococcal Vaccine Polyvalent Market

The global market for Pneumococcal Vaccine Polyvalent was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Pneumococcal vaccines are vaccines against the bacteria Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pneumococcal Vaccine Polyvalent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal Vaccine Polyvalent.

The Pneumococcal Vaccine Polyvalent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pneumococcal Vaccine Polyvalent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pneumococcal Vaccine Polyvalent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pneumococcal Vaccine Polyvalent Market Report

Report Metric	Details
Report Name	Pneumococcal Vaccine Polyvalent Market
CAGR	5%
Segment by Type	Prevnar 13 Pneumovax23
Segment by Application	18 Years and Younger 19 To 64 Years Old 65 Years and Older
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck & Co., Pfizer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pneumococcal Vaccine Polyvalent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pneumococcal Vaccine Polyvalent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pneumococcal Vaccine Polyvalent Market report?

Ans: The main players in the Pneumococcal Vaccine Polyvalent Market are Merck & Co., Pfizer

What are the Application segmentation covered in the Pneumococcal Vaccine Polyvalent Market report?

Ans: The Applications covered in the Pneumococcal Vaccine Polyvalent Market report are 18 Years and Younger, 19 To 64 Years Old, 65 Years and Older

What are the Type segmentation covered in the Pneumococcal Vaccine Polyvalent Market report?

Ans: The Types covered in the Pneumococcal Vaccine Polyvalent Market report are Prevnar 13, Pneumovax23

Recommended Reports

Human Vaccines

Pneumonia & Meningitis

Vaccine Devices & Packaging

1 Pneumococcal Vaccine Polyvalent Market Overview

1.1 Product Definition

1.2 Pneumococcal Vaccine Polyvalent by Type

1.2.1 Global Pneumococcal Vaccine Polyvalent Market Value Comparison by Type (2024 VS 2031)

1.2.2 Prevnar 13

1.2.3 Pneumovax23

1.3 Pneumococcal Vaccine Polyvalent by Application

1.3.1 Global Pneumococcal Vaccine Polyvalent Market Value by Application (2024 VS 2031)

1.3.2 18 Years and Younger

1.3.3 19 To 64 Years Old

1.3.4 65 Years and Older

1.4 Global Pneumococcal Vaccine Polyvalent Market Size Estimates and Forecasts

1.4.1 Global Pneumococcal Vaccine Polyvalent Revenue 2020-2031

1.4.2 Global Pneumococcal Vaccine Polyvalent Sales 2020-2031

1.4.3 Global Pneumococcal Vaccine Polyvalent Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Pneumococcal Vaccine Polyvalent Market Competition by Manufacturers

2.1 Global Pneumococcal Vaccine Polyvalent Sales Market Share by Manufacturers (2020-2025)

2.2 Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Pneumococcal Vaccine Polyvalent Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Pneumococcal Vaccine Polyvalent, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pneumococcal Vaccine Polyvalent, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pneumococcal Vaccine Polyvalent, Product Type & Application

2.7 Global Key Manufacturers of Pneumococcal Vaccine Polyvalent, Date of Enter into This Industry

2.8 Global Pneumococcal Vaccine Polyvalent Market Competitive Situation and Trends

2.8.1 Global Pneumococcal Vaccine Polyvalent Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Pneumococcal Vaccine Polyvalent Players Market Share by Revenue

2.8.3 Global Pneumococcal Vaccine Polyvalent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Pneumococcal Vaccine Polyvalent Market Scenario by Region

3.1 Global Pneumococcal Vaccine Polyvalent Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Pneumococcal Vaccine Polyvalent Sales by Region: 2020-2031

3.2.1 Global Pneumococcal Vaccine Polyvalent Sales by Region: 2020-2025

3.2.2 Global Pneumococcal Vaccine Polyvalent Sales by Region: 2026-2031

3.3 Global Pneumococcal Vaccine Polyvalent Revenue by Region: 2020-2031

3.3.1 Global Pneumococcal Vaccine Polyvalent Revenue by Region: 2020-2025

3.3.2 Global Pneumococcal Vaccine Polyvalent Revenue by Region: 2026-2031

3.4 North America Pneumococcal Vaccine Polyvalent Market Facts & Figures by Country

3.4.1 North America Pneumococcal Vaccine Polyvalent Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Pneumococcal Vaccine Polyvalent Sales by Country (2020-2031)

3.4.3 North America Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Pneumococcal Vaccine Polyvalent Market Facts & Figures by Country

3.5.1 Europe Pneumococcal Vaccine Polyvalent Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Pneumococcal Vaccine Polyvalent Sales by Country (2020-2031)

3.5.3 Europe Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pneumococcal Vaccine Polyvalent Market Facts & Figures by Region

3.6.1 Asia Pacific Pneumococcal Vaccine Polyvalent Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Pneumococcal Vaccine Polyvalent Sales by Region (2020-2031)

3.6.3 Asia Pacific Pneumococcal Vaccine Polyvalent Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Pneumococcal Vaccine Polyvalent Market Facts & Figures by Country

3.7.1 Latin America Pneumococcal Vaccine Polyvalent Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Pneumococcal Vaccine Polyvalent Sales by Country (2020-2031)

3.7.3 Latin America Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Pneumococcal Vaccine Polyvalent Market Facts & Figures by Country

3.8.1 Middle East and Africa Pneumococcal Vaccine Polyvalent Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Country (2020-2031)

3.8.3 Middle East and Africa Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Pneumococcal Vaccine Polyvalent Sales by Type (2020-2031)

4.1.1 Global Pneumococcal Vaccine Polyvalent Sales by Type (2020-2025)

4.1.2 Global Pneumococcal Vaccine Polyvalent Sales by Type (2026-2031)

4.1.3 Global Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2020-2031)

4.2 Global Pneumococcal Vaccine Polyvalent Revenue by Type (2020-2031)

4.2.1 Global Pneumococcal Vaccine Polyvalent Revenue by Type (2020-2025)

4.2.2 Global Pneumococcal Vaccine Polyvalent Revenue by Type (2026-2031)

4.2.3 Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Type (2020-2031)

4.3 Global Pneumococcal Vaccine Polyvalent Price by Type (2020-2031)

5 Segment by Application

5.1 Global Pneumococcal Vaccine Polyvalent Sales by Application (2020-2031)

5.1.1 Global Pneumococcal Vaccine Polyvalent Sales by Application (2020-2025)

5.1.2 Global Pneumococcal Vaccine Polyvalent Sales by Application (2026-2031)

5.1.3 Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2020-2031)

5.2 Global Pneumococcal Vaccine Polyvalent Revenue by Application (2020-2031)

5.2.1 Global Pneumococcal Vaccine Polyvalent Revenue by Application (2020-2025)

5.2.2 Global Pneumococcal Vaccine Polyvalent Revenue by Application (2026-2031)

5.2.3 Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Application (2020-2031)

5.3 Global Pneumococcal Vaccine Polyvalent Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Merck & Co.

6.1.1 Merck & Co. Company Information

6.1.2 Merck & Co. Description and Business Overview

6.1.3 Merck & Co. Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Merck & Co. Pneumococcal Vaccine Polyvalent Product Portfolio

6.1.5 Merck & Co. Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Company Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Pfizer Pneumococcal Vaccine Polyvalent Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pneumococcal Vaccine Polyvalent Industry Chain Analysis

7.2 Pneumococcal Vaccine Polyvalent Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pneumococcal Vaccine Polyvalent Production Mode & Process Analysis

7.4 Pneumococcal Vaccine Polyvalent Sales and Marketing

7.4.1 Pneumococcal Vaccine Polyvalent Sales Channels

7.4.2 Pneumococcal Vaccine Polyvalent Distributors

7.5 Pneumococcal Vaccine Polyvalent Customer Analysis

8 Pneumococcal Vaccine Polyvalent Market Dynamics

8.1 Pneumococcal Vaccine Polyvalent Industry Trends

8.2 Pneumococcal Vaccine Polyvalent Market Drivers

8.3 Pneumococcal Vaccine Polyvalent Market Challenges

8.4 Pneumococcal Vaccine Polyvalent Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Merck

Pfizer Inc

List of Tables

Table 1. Global Pneumococcal Vaccine Polyvalent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Pneumococcal Vaccine Polyvalent Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Pneumococcal Vaccine Polyvalent Market Competitive Situation by Manufacturers in 2024

Table 4. Global Pneumococcal Vaccine Polyvalent Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Pneumococcal Vaccine Polyvalent Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Pneumococcal Vaccine Polyvalent Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Pneumococcal Vaccine Polyvalent, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Pneumococcal Vaccine Polyvalent, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Pneumococcal Vaccine Polyvalent, Product Type & Application

Table 12. Global Key Manufacturers of Pneumococcal Vaccine Polyvalent, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Pneumococcal Vaccine Polyvalent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Vaccine Polyvalent as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Pneumococcal Vaccine Polyvalent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Pneumococcal Vaccine Polyvalent Sales by Region (2020-2025) & (K Units)

Table 18. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2020-2025)

Table 19. Global Pneumococcal Vaccine Polyvalent Sales by Region (2026-2031) & (K Units)

Table 20. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2026-2031)

Table 21. Global Pneumococcal Vaccine Polyvalent Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Region (2020-2025)

Table 23. Global Pneumococcal Vaccine Polyvalent Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Region (2026-2031)

Table 25. North America Pneumococcal Vaccine Polyvalent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Pneumococcal Vaccine Polyvalent Sales by Country (2020-2025) & (K Units)

Table 27. North America Pneumococcal Vaccine Polyvalent Sales by Country (2026-2031) & (K Units)

Table 28. North America Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Pneumococcal Vaccine Polyvalent Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Pneumococcal Vaccine Polyvalent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Pneumococcal Vaccine Polyvalent Sales by Country (2020-2025) & (K Units)

Table 32. Europe Pneumococcal Vaccine Polyvalent Sales by Country (2026-2031) & (K Units)

Table 33. Europe Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Pneumococcal Vaccine Polyvalent Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Pneumococcal Vaccine Polyvalent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Pneumococcal Vaccine Polyvalent Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Pneumococcal Vaccine Polyvalent Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Pneumococcal Vaccine Polyvalent Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Pneumococcal Vaccine Polyvalent Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Pneumococcal Vaccine Polyvalent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Pneumococcal Vaccine Polyvalent Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Pneumococcal Vaccine Polyvalent Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Pneumococcal Vaccine Polyvalent Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Pneumococcal Vaccine Polyvalent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Pneumococcal Vaccine Polyvalent Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Pneumococcal Vaccine Polyvalent Sales (K Units) by Type (2020-2025)

Table 51. Global Pneumococcal Vaccine Polyvalent Sales (K Units) by Type (2026-2031)

Table 52. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2020-2025)

Table 53. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2026-2031)

Table 54. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Type (2020-2025)

Table 57. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Type (2026-2031)

Table 58. Global Pneumococcal Vaccine Polyvalent Price (USD/Unit) by Type (2020-2025)

Table 59. Global Pneumococcal Vaccine Polyvalent Price (USD/Unit) by Type (2026-2031)

Table 60. Global Pneumococcal Vaccine Polyvalent Sales (K Units) by Application (2020-2025)

Table 61. Global Pneumococcal Vaccine Polyvalent Sales (K Units) by Application (2026-2031)

Table 62. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2020-2025)

Table 63. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2026-2031)

Table 64. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Application (2020-2025)

Table 67. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Application (2026-2031)

Table 68. Global Pneumococcal Vaccine Polyvalent Price (USD/Unit) by Application (2020-2025)

Table 69. Global Pneumococcal Vaccine Polyvalent Price (USD/Unit) by Application (2026-2031)

Table 70. Merck & Co. Company Information

Table 71. Merck & Co. Description and Business Overview

Table 72. Merck & Co. Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Merck & Co. Pneumococcal Vaccine Polyvalent Product

Table 74. Merck & Co. Recent Developments/Updates

Table 75. Pfizer Company Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Pfizer Pneumococcal Vaccine Polyvalent Product

Table 79. Pfizer Recent Developments/Updates

Table 80. Key Raw Materials Lists

Table 81. Raw Materials Key Suppliers Lists

Table 82. Pneumococcal Vaccine Polyvalent Distributors List

Table 83. Pneumococcal Vaccine Polyvalent Customers List

Table 84. Pneumococcal Vaccine Polyvalent Market Trends

Table 85. Pneumococcal Vaccine Polyvalent Market Drivers

Table 86. Pneumococcal Vaccine Polyvalent Market Challenges

Table 87. Pneumococcal Vaccine Polyvalent Market Restraints

Table 88. Research Programs/Design for This Report

Table 89. Key Data Information from Secondary Sources

Table 90. Key Data Information from Primary Sources

Table 91. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pneumococcal Vaccine Polyvalent

Figure 2. Global Pneumococcal Vaccine Polyvalent Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pneumococcal Vaccine Polyvalent Market Share by Type: 2024 & 2031

Figure 4. Prevnar 13 Product Picture

Figure 5. Pneumovax23 Product Picture

Figure 6. Global Pneumococcal Vaccine Polyvalent Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Pneumococcal Vaccine Polyvalent Market Share by Application: 2024 & 2031

Figure 8. 18 Years and Younger

Figure 9. 19 To 64 Years Old

Figure 10. 65 Years and Older

Figure 11. Global Pneumococcal Vaccine Polyvalent Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Pneumococcal Vaccine Polyvalent Market Size (2020-2031) & (US$ Million)

Figure 13. Global Pneumococcal Vaccine Polyvalent Sales (2020-2031) & (K Units)

Figure 14. Global Pneumococcal Vaccine Polyvalent Average Price (USD/Unit) & (2020-2031)

Figure 15. Pneumococcal Vaccine Polyvalent Report Years Considered

Figure 16. Pneumococcal Vaccine Polyvalent Sales Share by Manufacturers in 2024

Figure 17. Global Pneumococcal Vaccine Polyvalent Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Pneumococcal Vaccine Polyvalent Players: Market Share by Revenue in Pneumococcal Vaccine Polyvalent in 2024

Figure 19. Pneumococcal Vaccine Polyvalent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Pneumococcal Vaccine Polyvalent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2020-2031)

Figure 22. North America Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2020-2031)

Figure 23. U.S. Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2020-2031)

Figure 26. Europe Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2020-2031)

Figure 27. Germany Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Pneumococcal Vaccine Polyvalent Revenue Market Share by Region (2020-2031)

Figure 34. China Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Taiwan Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Philippines Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2020-2031)

Figure 45. Latin America Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Pneumococcal Vaccine Polyvalent by Type (2020-2031)

Figure 55. Global Revenue Market Share of Pneumococcal Vaccine Polyvalent by Type (2020-2031)

Figure 56. Global Pneumococcal Vaccine Polyvalent Price (USD/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Pneumococcal Vaccine Polyvalent by Application (2020-2031)

Figure 58. Global Revenue Market Share of Pneumococcal Vaccine Polyvalent by Application (2020-2031)

Figure 59. Global Pneumococcal Vaccine Polyvalent Price (USD/Unit) by Application (2020-2031)

Figure 60. Pneumococcal Vaccine Polyvalent Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Pneumococcal Polysaccharide Vaccine Market Research Report 2024

Global Polyvalent Streptococcus Pneumococcal Vaccines Market Research Report 2025

Streptococcus Pneumoniae Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Research Report 2025

Global 13 Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Research Report 2024

23 valent Pneumococcal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global 13 Valent Pneumococcal Conjugate Vaccine Market Research Report 2024

Pneumococcal Bacteria Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

13 Valent Pneumococcal Polysaccharide Conjugate Vaccine PCV13 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pneumococcal Conjugate Vaccine PCV Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pneumococcal Vaccination Market Research Report 2025

Global Pneumococcal Testing Market Research Report 2024

Pneumococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Research Report 2024

Global Pneumonia Vaccine Market Insights Forecast to 2030

Global Streptococcus Pneumoniae Antibodies Market Research Report 2024

Meningococcal Disease Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Equine Rhinopneumonitis Vaccine Market Research Report 2024

Cervical Cancer Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions